ClinicalTrials.Veeva

Menu

Carotid Intima Media Thickness (CIMT) in Epistaxis

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Epistaxis
Atherosclerosis

Treatments

Diagnostic Test: Ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT03092973
CIMT in Epistaxis

Details and patient eligibility

About

Epistaxis is a very frequent emergency among adults and often needs specialised treatment in an ENT-department. Among others, atherosclerosis is often named as a reason for an increased risk for Epistaxis. To evaluate whether or not this is the case, the investigators examined the carotid intima media thickness via ultrasound in patients who were treated in the ENT-department of the University Hospital of Zurich.

Enrollment

82 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • active or very recently active anterior or posterior epistaxis
  • at least 18 years old

Exclusion criteria

  • posttraumatic or postoperative epistaxis

Trial design

82 participants in 2 patient groups

Epistaxis Group
Treatment:
Diagnostic Test: Ultrasound
Control Group
Treatment:
Diagnostic Test: Ultrasound

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems